These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 153953)

  • 1. Studies on levamisole, a potentially useful drug in the treatment of Behçet's syndrome.
    Sampson D
    J Oral Pathol; 1978; 7(6):383-6. PubMed ID: 153953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose dependence of immunopotentiation and tumor regression induced by levamisole.
    Sampson D; Peters TG; Lewis JD; Metzig J; Kurtz BE
    Cancer Res; 1977 Oct; 37(10):3526-9. PubMed ID: 409485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopotentiation and tumor inhibition with levamisole.
    Sampson D
    Cancer Treat Rep; 1978 Nov; 62(11):1623-5. PubMed ID: 728892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Behcet's syndrome with levamisole.
    de Merieux P; Spitler LE; Paulus HE
    Arthritis Rheum; 1981 Jan; 24(1):64-70. PubMed ID: 7008801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of Behcet's syndrome with levamisole.
    Lavery HA; Pinkerton JH
    Br J Dermatol; 1985 Sep; 113(3):372-3. PubMed ID: 4063177
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of Behcet's disease with levamisole.
    Hamza M; Ayed K; Ben Ayed H
    Arthritis Rheum; 1982 Jun; 25(6):714-5. PubMed ID: 7092974
    [No Abstract]   [Full Text] [Related]  

  • 7. [Association of agramulocytosis caused by levamisole and HLA B27 in Behçet's disease].
    Hamza M; Ben Ayed H
    Nouv Presse Med; 1979 Oct; 8(39):3167-8. PubMed ID: 537876
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the responses of peripheral blood lymphocytes to mitogens in patients with Behçet's disease (author's transl)].
    Kondo J; Kobayashi K; Ando F; Kodera Y
    Nippon Ganka Gakkai Zasshi; 1979 Jul; 83(7):998-1003. PubMed ID: 495384
    [No Abstract]   [Full Text] [Related]  

  • 9. [Behçet's disease. Circulating immune complexes and abnormalities of polynuclear chemotaxis].
    Graisely B; Margueritte-Renard O; Cloarec M; Debray J
    Nouv Presse Med; 1979 Mar; 8(11):867. PubMed ID: 450661
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunocompetent cells and lymphocyte reactivity to mitogens in levamisole-treated brain tumor children.
    Hajnzić TF; Kastelan M; Lukac J; Hajnzić T
    Pediatr Hematol Oncol; 1999; 16(4):335-40. PubMed ID: 10407870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated immune functions and immunoregulatory cells in Behçet's syndrome.
    Victorino RM; Ryan P; Hughes GR; Hodgson HJ
    Clin Exp Immunol; 1982 Apr; 48(1):121-8. PubMed ID: 6211313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of Behçet's disease].
    Hamza M; Ben Ayed H
    Tunis Med; 1980; 58(1-2):394-6. PubMed ID: 7210186
    [No Abstract]   [Full Text] [Related]  

  • 13. Can therapeutic considerations provide clues to the etiology of aphthous stomatitis and Behçet's syndrome?
    Rytel MW
    J Oral Pathol; 1978; 7(6):372-5. PubMed ID: 105095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspects of lymphocyte function in Behçet's disease.
    Haim S; Mekori T; Sobel JD; Robinson E
    Dermatologica; 1976; 153(1):34-7. PubMed ID: 1086808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical observations on 3 cases of Behçet's syndrome].
    Baldin C; Beltrame M; Cecchi W; Robotti MP
    G Stomatol Ortognatodonzia; 1985; 4(4):49-55. PubMed ID: 3870431
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental study on levamisole modulation of antitumor immunity--1].
    Saji S; Ooshita H; Adachi Y; Yamamoto S; Takekoshi T; Sakata K
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1418-26. PubMed ID: 6985198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behcet's syndrome.
    James DG
    N Engl J Med; 1979 Aug; 301(8):431-2. PubMed ID: 460347
    [No Abstract]   [Full Text] [Related]  

  • 18. Functional aberration of T cell subsets in patients with Behçet's disease.
    Sakane T; Kotani H; Takada S; Tsunematsu T
    Arthritis Rheum; 1982 Nov; 25(11):1343-51. PubMed ID: 6215926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-alpha level in patients with mucocutaneous type of Behcet's disease.
    Sun A; Wang YP; Chia JS; Liu BY; Chiang CP
    J Oral Pathol Med; 2009 May; 38(5):401-5. PubMed ID: 19434815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating effects of levamisole (NSC-177023) on human lymphocyte response in vitro.
    Lichtenfeld JL; Desner MR; Wiernik PH; Mardiney MR
    Cancer Treat Rep; 1976 May; 60(5):571-4. PubMed ID: 991144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.